These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2446483)
21. Methadone-maintained patients. Effect of methadone on plasma testosterone, FSH, LH, and prolactin. Cushman P; Kreek MJ N Y State J Med; 1974 Oct; 74(11):1970-3. PubMed ID: 4528642 [TBL] [Abstract][Full Text] [Related]
22. Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study. Erb K; Pechstein B; Schueler A; Engel J; Hermann R Clin Pharmacol Ther; 2000 Jun; 67(6):660-9. PubMed ID: 10872648 [TBL] [Abstract][Full Text] [Related]
23. [Value of testosterone, FSH and LH on plasma in patients with prostatic adenoma and carcinoma before and after different hormonal treatments]. Garcia de la Peña E; Ramos F; Horcajada C; Cifuentes Delatte L; Vivanco F Rev Clin Esp; 1978 Jan; 148(1):19-23. PubMed ID: 76325 [No Abstract] [Full Text] [Related]
24. Medical castration of males with megestrol acetate and small doses of diethylstilbestrol. Geller J; Albert J; Yen SS; Geller S; Loza D J Clin Endocrinol Metab; 1981 Mar; 52(3):576-80. PubMed ID: 6161942 [TBL] [Abstract][Full Text] [Related]
25. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma. Tomić R Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040 [TBL] [Abstract][Full Text] [Related]
26. Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens. Boyns AR; Cole EN; Phillips ME; Hillier SG; Cameron EH; Griffiths K; Shahmanesh M; Feneley RC; Hartog M Eur J Cancer (1965); 1974 Jul; 10(7):445-9. PubMed ID: 4376085 [No Abstract] [Full Text] [Related]
27. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations. Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543 [TBL] [Abstract][Full Text] [Related]
28. Effects of intravenous administration of high dose-diethylstilbestrol diphosphate on serum hormonal levels in patients with hormone-refractory prostate cancer. Kitahara S; Umeda H; Yano M; Koga F; Sumi S; Moriguchi H; Hosoya Y; Honda M; Yoshida K Endocr J; 1999 Oct; 46(5):659-64. PubMed ID: 10670751 [TBL] [Abstract][Full Text] [Related]
29. Lowering prolactin level in a hyperprolactinemic man: responses of luteinizing hormone, follicle-stimulating hormone, and testosterone. Davis JL Arch Intern Med; 1982 Jan; 142(1):146-8. PubMed ID: 6797361 [TBL] [Abstract][Full Text] [Related]
30. [Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate]. Hayashi T; Takenawa J; Ryoji O; Hiura M; Taki Y; Kiriyama T Hinyokika Kiyo; 1989 May; 35(5):807-13. PubMed ID: 2478002 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog. Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095 [TBL] [Abstract][Full Text] [Related]
33. Medical castration with megestrol acetate and minidose of diethylstilbestrol. Geller J; Albert J; Yen SS; Geller S; Loza D Urology; 1981 Apr; 17(4 Suppl):27-33. PubMed ID: 6782738 [No Abstract] [Full Text] [Related]
34. [Clinical evaluation of enantone in the treatment of prostate cancer]. Zhang L; Tao D; Wang S Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):218-20. PubMed ID: 10920902 [TBL] [Abstract][Full Text] [Related]
35. [Hormonal treatment of carcinoma of the prostate]. Obata K; Kobayashi H; Murase T; Ohisi M Hinyokika Kiyo; 1991 Aug; 37(8):809-16. PubMed ID: 1720272 [TBL] [Abstract][Full Text] [Related]
36. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma. Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431 [TBL] [Abstract][Full Text] [Related]
37. [Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate Part I: Nocturnal penile tumescence monitoring]. Kumamoto Y; Yamaguchi Y; Sato Y; Suzuki R; Tanda H; Kato S; Mori K; Matsumoto H; Maki A; Kadono M Hinyokika Kiyo; 1990 Feb; 36(2):213-26. PubMed ID: 1693037 [TBL] [Abstract][Full Text] [Related]
38. [Effects of chlormadinone acetate therapy on the pituitary-testicular system in prostatic cancer]. Nishimura R; Hosaka M; Mamiya N; Kimihira A; Konno M Horumon To Rinsho; 1977 Sep; 25(9):1013-8. PubMed ID: 72621 [No Abstract] [Full Text] [Related]
39. FSH and LH elevation after radiation for treatment of cancer of the prostate. Seal US Invest Urol; 1979 Jan; 16(4):278-80. PubMed ID: 429120 [TBL] [Abstract][Full Text] [Related]
40. [The clinical effect of chlormadinone acetate on carcinoma of the prostate (author's transl)]. Matsuoka M; Mayuzumi T; Shida K Nihon Hinyokika Gakkai Zasshi; 1980 Sep; 71(9):1010-23. PubMed ID: 6162051 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]